Pfizer Reports Second-Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Pfizer (PFE) Tops Q2 EPS by 12c, Raises FY Guidance
July 28, 2020 6:47 AM EDT(Updated - July 28, 2020 6:49 AM EDT)
Pfizer (NYSE: PFE) reported Q2 EPS of $0.78, $0.12 better than the analyst estimate of $0.66. Revenue for the quarter came in at $11.8 billion versus the consensus estimate of $11.55 billion.
GUIDANCE:
Pfizer sees 2020 EPS of $2.85-$2.95, versus the... More
